CIPLA FDA Approval ANDA 210255

ANDA 210255

CIPLA

FDA Drug Application

Application #210255

Application Sponsors

ANDA 210255CIPLA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL20MG0TADALAFILTADALAFIL

FDA Submissions

UNKNOWN; ORIG1AP2019-02-05STANDARD
LABELING; LabelingSUPPL2AP2021-03-17STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15

TE Codes

001PrescriptionAB2

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210255
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TADALAFIL","activeIngredients":"TADALAFIL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/05\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-02-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.